2024 KSoLA Consensus on Secondary Dyslipidemia.
Diagnosis
Drug-related side effects and adverse reactions
Food
Lipoproteins
Metabolism
Journal
Journal of lipid and atherosclerosis
ISSN: 2287-2892
Titre abrégé: J Lipid Atheroscler
Pays: Korea (South)
ID NLM: 101610890
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
received:
08
05
2024
revised:
20
07
2024
accepted:
12
08
2024
medline:
2
10
2024
pubmed:
2
10
2024
entrez:
2
10
2024
Statut:
ppublish
Résumé
Elevated blood cholesterol and triglyceride levels induced by secondary causes are frequently observed. The identification and appropriate handling of these causes are essential for secondary dyslipidemia treatment. Major secondary causes of hypercholesterolemia and hypertriglyceridemia include an unhealthy diet, diseases and metabolic conditions affecting lipid levels, and therapeutic side effects. It is imperative to correct secondary causes prior to initiating conventional lipid-lowering therapy. Guideline-based lipid therapy can then be administered based on the subsequent lipid levels.
Identifiants
pubmed: 39355405
doi: 10.12997/jla.2024.13.3.215
pmc: PMC11439749
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
215-231Informations de copyright
© 2024 The Korean Society of Lipid and Atherosclerosis.
Déclaration de conflit d'intérêts
Conflict of Interest: The authors have no conflicts of interest to declare.